Argo Biopharma begins patient dosing in phase II trials of siRNA therapy BW-40202: Shanghai, China Wednesday, April 22, 2026, 15:00 Hrs [IST] Argo Biopharmaceutical Co., Ltd. (Arg ...
Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage small interfering RNA (siRNA) therapeutics company, today announced the first patient has been dosed in multiple Phase II studies of ...
If your immune system overreacts to pollen or other allergens, a diet rich in compounds that boost immune health and reduce ...
A 2026 informational report on Quietum Plus ear ringing relief positioning, auditory nerve support ingredients, proprietary ...
The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
New findings from a DETOUR2 substudy show that minimally invasive percutaneous transmural arterial bypass (PTAB) may offer a ...
A widely publicised Cochrane review published on April 16, 2026, set out to synthesise evidence on the efficacy and safety of amyloid β-targeting monoclonal antibodies for Alzheimer's disease.1 The ...
A detailed analysis of T-cell redirecting therapies in oncology, comparing the mechanisms of bispecific antibodies and CAR T ...
A global clinical trial led by NYU Langone Health found that specific gut microbiome patterns can predict melanoma recurrence after surgery and immunotherapy with up to 94% accuracy. The study ...
Objective Cardiovascular diseases are a leading cause of morbidity and mortality in SLE. In this target population, ...
Hosted on MSN
Boost your brain with smart daily habits
Your brain can change, grow, and strengthen at any age—if you give it the right challenges. Research shows that targeted cognitive training, exercise, and lifestyle habits can enhance memory, improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results